New York Life Investment Management LLC Dyne Therapeutics, Inc. Transaction History

New York Life Investment Management LLC

  • $9.63 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024
SELL
$6.62 - $13.64 $4,607 - $9,493
-696 Reduced 2.25%
30,210 $401,000
Q3 2023

Nov 07, 2023
SELL
$8.6 - $12.18 $41,882 - $59,316
-4,870 Reduced 13.61%
30,906 $276,000
Q2 2023

Aug 04, 2023
SELL
$8.53 - $14.28 $56,238 - $94,148
-6,593 Reduced 15.56%
35,776 $402,000
Q1 2023

May 08, 2023
BUY
$10.88 - $15.0 $460,974 - $635,535
42,369 New
42,369 $488,000

Others Institutions Holding DYN

# of Institutions
209
Shares Held
102M
Call Options Held
234K
Put Options Held
238K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email